Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
National Taiwan University Hospital |
---|---|
Information provided by: | National Taiwan University Hospital |
ClinicalTrials.gov Identifier: | NCT00745927 |
It has been reported that carbon dioxide (CO2) insufflation can reduce patient pain and abdominal discomfort during and after colonoscopy. Its safety and efficacy during colonoscopy even under sedation has been already assessed in some earlier trials.1 Air insufflation is still the standard method, however, because of a lack of suitable equipment and continued technical improvement in colonoscopy.
In laparoscopic surgery, CO2 insufflation is widely applied and safely used with the patient under general anesthesia. CO2 insufflation is also applied for CT colonography for reduction of discomfort during or after procedure.2 During endoscopic procedure for colorectal neoplasia resection, however, long procedural time may increase not only the degree of discomfort during and after the procedure but also the risk of perforation. In addition to laparoscopic surgery, CO2 insufflation has also been applied to other endoscopic procedures. 1, 3-5 Saito et al reported the application of CO2 insufflation in Endoscopic submucosal dissection (ESD) of colorectal neoplasia in a prospective study in which their average procedural time using CO2 insufflation was 90 minutes under conscious sedation with average of 5.6 mg of midazolam. When compared with control group using room air, statistically negligible difference of pCO2 was observed with significant difference in abdominal discomfort.6 Screening colonoscopy, which can be completed within 15 minutes if no lesion being detected, requires high screenee satisfaction so as to improve patient compliance. In the setting of colonoscopy after positive FOBT, the attendance rate for secondary colonoscopy was around 60 to 70 % according to the data demonstrated in previous RCT and population-based studies. With application of CO2 insufflation, further improvement of patient compliance can be anticipated.
This study aims to investigate whether use of CO2 insufflations can reduce examinee discomfort in comparison with air.
Condition | Intervention |
---|---|
Colorectal Neoplasm Colorectal Cancer |
Other: CO2 insufflations during colonoscopy |
Study Type: | Interventional |
Study Design: | Screening, Randomized, Double Blind (Subject, Caregiver, Outcomes Assessor), Uncontrolled, Parallel Assignment, Safety/Efficacy Study |
Official Title: | Application of CO2 Insufflations in Colonoscopy Examination-A Single-Blinded Randomized Trial |
Estimated Enrollment: | 400 |
Study Start Date: | June 2008 |
Estimated Study Completion Date: | November 2008 |
Estimated Primary Completion Date: | November 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: No Intervention
Air insufflations used in colonoscopy: room air
|
|
2: Active Comparator
Air insufflations used in colonoscopy: CO2
|
Other: CO2 insufflations during colonoscopy
CO2 insufflations during whole procedure of colonoscopy
|
Inclusion criteria: Subjects who receive Screening colonoscopy or secondary colonoscopy Exclusion criteria: subjects who have COPD or cardiovascular diseases
Post-colonoscopy discomfort will be measured and obtained from the screenee at several time points using visual analogue pain scoring system:
Statistical analysis:
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contact: Han-Mo Chiu, M.D | 886-2-23123456 ext 63354 | hanmochiu@ntu.edu.tw |
Taiwan | |
National Taiwan University Hospital | Recruiting |
Taipei, Taiwan, 100 | |
Contact: Han-Mo Chiu, MD 886-2-23123456 ext 63354 hanmochiu@ntu.edu.tw | |
Principal Investigator: Han-Mo Chiu, MD |
Study Director: | Hsiu-Po Wang, MD | National Taiwan University Hospital |
Responsible Party: | National Taiwan Univesity Hospital ( Han-Mo Chiu ) |
Study ID Numbers: | 200802031R |
Study First Received: | August 31, 2008 |
Last Updated: | September 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00745927 |
Health Authority: | Taiwan: Department of Health |
Colorectal neoplasm Colorectal cancer Screening colonoscopy CO2 insufflations Colonoscopy |
Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Colonic Diseases Gastrointestinal Neoplasms |
Intestinal Diseases Rectal Diseases Intestinal Neoplasms Colorectal Neoplasms |
Neoplasms Neoplasms by Site |